BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24639435)

  • 1. Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort.
    Berge G; Sando SB; Rongve A; Aarsland D; White LR
    J Neurol Neurosurg Psychiatry; 2014 Nov; 85(11):1227-31. PubMed ID: 24639435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies.
    Singleton AB; Wharton A; O'Brien KK; Walker MP; McKeith IG; Ballard CG; O'Brien J; Perry RH; Ince PG; Edwardson JA; Morris CM
    Dement Geriatr Cogn Disord; 2002; 14(4):167-75. PubMed ID: 12411758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction with the MAPT H1H1 Genotype Increases Dementia Risk in APOE ε4 Carriers in a Population of Southern India.
    Jairani PS; Aswathy PM; Gopala S; Verghese J; Mathuranath PS
    Dement Geriatr Cogn Disord; 2016; 42(5-6):255-264. PubMed ID: 27705964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.
    Sando SB; Melquist S; Cannon A; Hutton ML; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly JO
    BMC Neurol; 2008 Apr; 8():9. PubMed ID: 18416843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E4 frequencies in a Japanese population with Alzheimer's disease and dementia with Lewy bodies.
    Kobayashi S; Tateno M; Park TW; Utsumi K; Sohma H; Ito YM; Kokai Y; Saito T
    PLoS One; 2011 Apr; 6(4):e18569. PubMed ID: 21552550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between APOE polymorphisms and seven diseases with cognitive impairment including Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies in southeast China.
    Chen KL; Sun YM; Zhou Y; Zhao QH; Ding D; Guo QH
    Psychiatr Genet; 2016 Jun; 26(3):124-31. PubMed ID: 26981880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apolipoprotein E4 in dementia with Lewy bodies].
    Carrillo García F; Gil Néciga E; Alberca R; García-Solís D; Millán J; Rodríguez Uranga JJ; Franco E; Mir P; Suárez A; García R; Serrano-Pozo A; Pérez-Díaz H; Polo J
    Neurologia; 2008 Apr; 23(3):152-6. PubMed ID: 18370334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Uncommon, Noncoding Variants in the APOE Region With Risk of Alzheimer Disease in Adults of European Ancestry.
    Blue EE; Cheng A; Chen S; Yu CE;
    JAMA Netw Open; 2020 Oct; 3(10):e2017666. PubMed ID: 33090224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old.
    Berlau DJ; Corrada MM; Head E; Kawas CH
    Neurology; 2009 Mar; 72(9):829-34. PubMed ID: 19255410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOE-ε4 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies.
    Saeed U; Mirza SS; MacIntosh BJ; Herrmann N; Keith J; Ramirez J; Nestor SM; Yu Q; Knight J; Swardfager W; Potkin SG; Rogaeva E; St George-Hyslop P; Black SE; Masellis M
    Alzheimers Dement; 2018 Sep; 14(9):1137-1147. PubMed ID: 29782824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease pathology explains association between dementia with Lewy bodies and APOE-ε4/TOMM40 long poly-T repeat allele variants.
    Prokopenko I; Miyakawa G; Zheng B; Heikkinen J; Petrova Quayle D; Udeh-Momoh C; Claringbould A; Neumann J; Haytural H; Kaakinen MA; Loizidou E; Meissner E; Bertram L; ; Gveric DO; Gentleman SM; Attems J; Perneczky R; Arzberger T; Muglia P; Lill CM; Parkkinen L; Middleton LT
    Alzheimers Dement (N Y); 2019; 5():814-824. PubMed ID: 31788537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between BDNF Val66Met polymorphism and Alzheimer disease, dementia with Lewy bodies, and Pick disease.
    Fehér A; Juhász A; Rimanóczy A; Kálmán J; Janka Z
    Alzheimer Dis Assoc Disord; 2009; 23(3):224-8. PubMed ID: 19812463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of APOE in atypical parkinsonism syndromes.
    Sabir MS; Blauwendraat C; Ahmed S; Serrano GE; Beach TG; Perkins M; Rice AC; Masliah E; Morris CM; Pihlstrom L; Pantelyat A; Resnick SM; Cookson MR; Hernandez DG; Albert M; Dawson TM; Rosenthal LS; Houlden H; Pletnikova O; Troncoso J; Scholz SW
    Neurobiol Dis; 2019 Jul; 127():142-146. PubMed ID: 30798004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of annexin A5 as a biomarker for Alzheimer's disease and dementia with lewy bodies.
    Sohma H; Imai S; Takei N; Honda H; Matsumoto K; Utsumi K; Matsuki K; Hashimoto E; Saito T; Kokai Y
    Front Aging Neurosci; 2013; 5():15. PubMed ID: 23576984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease.
    Drigalenko E; Poduslo S; Elston R
    Neurology; 1998 Jul; 51(1):131-5. PubMed ID: 9674791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease.
    Vijayaraghavan S; Darreh-Shori T; Rongve A; Berge G; Sando SB; White LR; Auestad BH; Witoelar A; Andreassen OA; Ulstein ID; Aarsland D
    J Alzheimers Dis; 2016; 50(2):567-76. PubMed ID: 26757188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective association of the ε2/ε3 heterozygote with Alzheimer's disease is strengthened by TOMM40-APOE variants in men.
    Kulminski AM; Philipp I; Loika Y; He L; Culminskaya I
    Alzheimers Dement; 2021 Nov; 17(11):1779-1787. PubMed ID: 34310032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects.
    Engelborghs S; Dermaut B; Goeman J; Saerens J; Mariën P; Pickut BA; Van den Broeck M; Serneels S; Cruts M; Van Broeckhoven C; De Deyn PP
    J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1148-51. PubMed ID: 12876259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dementia with Lewy bodies and Alzheimer's disease.
    Rosenberg CK; Cummings TJ; Saunders AM; Widico C; McIntyre LM; Hulette CM
    Acta Neuropathol; 2001 Dec; 102(6):621-6. PubMed ID: 11761723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.